An interventional study of Hip arthroscopic surgery and Standardized physical rehabilitation training in Femoroacetabular Impingement Syndrome, sponsored by Peking University Third Hospital. Recruiting at 1 site in China. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by Peking University Third Hospital · Not applicable, Interventional, and Treatment
This study aims to compare the therapeutic effects of three different treatment strategies for patients with femoroacetabular impingement. Participants will be randomly assigned to one of three groups: surgery combined with pre-rehabilitation, direct surgery without pre-rehabilitation, or rehabilitation alone. Researchers will follow-up participants and evaluate pain, joint function and other outcomes to find out which treatment works better.
Background and Rationale Femoroacetabular impingement (FAI) is a common sports-related disorder of the hip caused by abnormal anatomical morphology of the proximal femur and the acetabulum. Diagnosis requires the combination of patient-reported symptoms, physical examination findings, and imaging abnormalities. Affected patients typically present with activity-related groin or peritrochanteric pain, mechanical symptoms such as clicking, and reduced range of motion. If left untreated, repetitive abnormal osseous impingement can damage the acetabular labrum and articular cartilage, accelerating the degenerative progression toward hip osteoarthritis.
Current management strategies for FAI center on conservative rehabilitation (primarily physiotherapy) and minimally invasive hip arthroscopic surgery. However, the optimal treatment pathway among rehabilitation alone, direct surgery, and the combination of surgery with preoperative rehabilitation remains controversial, and high-level comparative evidence is lacking.
Physical rehabilitation and hip arthroscopy have distinct and complementary mechanisms of action, yet their relative efficacy and appropriate indications are not fully defined. Rehabilitation focuses on correcting abnormal movement patterns and strengthening pelvic and core stability; it is non-invasive and associated with fewer complications, but it cannot eliminate the underlying Cam- or Pincer-type osseous deformity. Consequently, patients with significant structural impingement often experience recurrent pain and difficulty returning to high-level sport after conservative treatment alone. In contrast, hip arthroscopy allows precise resection of the impinging osseous deformity and repair or reconstruction of the damaged labrum, and it has become the mainstream treatment for patients with moderate-to-severe disease. Nevertheless, functional recovery and long-term satisfaction after direct surgery vary considerably among individuals; a substantial proportion of patients experience delayed functional recovery and slow pain relief in the early postoperative period due to pre-existing muscle atrophy, impaired neuromuscular proprioception, and the physiological stress of surgical trauma.
Introducing prehabilitation into the perioperative management of FAI offers a promising approach to address this limitation. Preoperative exercise-based prehabilitation aims to improve patients' physiological reserve and neuromuscular compensation through targeted functional exercise, strength conditioning, and patient education before surgery, thereby improving tolerance of the surgical insult and accelerating postoperative recovery. Although a few randomized trials have suggested that a short preoperative prehabilitation program may improve certain early postoperative functional outcomes, current evidence remains insufficient to demonstrate sustained medium- and long-term gains in clinically meaningful patient-reported outcomes. More importantly, no prospective three-arm trial has directly compared surgery combined with prehabilitation, direct surgery, and standardized rehabilitation alone within a single evaluation framework, leaving clinicians without high-level evidence to guide stepped care decision-making.
Study Design
This is a prospective, randomized, three-arm, parallel-group controlled trial. Eligible participants are allocated in a 1:1:1 ratio to one of three arms:
Participants
Inclusion Criteria:
Presence of hip pain with imaging evidence of Cam- or Pincer-type femoroacetabular impingement morphology; Age ≥ 16 years; Able to provide written informed consent; Physician judgment that the patient is likely to benefit from hip arthroscopic surgery or a rehabilitation program.
Exclusion Criteria:
Concomitant hip osteoarthritis (Tönnis grade > 1, or joint space \< 2 mm on the anteroposterior pelvic radiograph); History of prior hip pathology, including Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, or avascular necrosis of the femoral head; History of prior hip trauma, including acetabular fracture, hip dislocation, or femoral neck fracture; Previous hip surgery (open or arthroscopic); Completion of a rehabilitation program specifically for FAIS within the past 12 months; Hip dysplasia (lateral center-edge angle \< 20°).
Note on bilateral disease: Patients with bilateral FAIS may be enrolled; only the more symptomatic hip is randomized and followed for the purposes of this study.
Interventions Rehabilitation Protocol (Arms A and C): The rehabilitation program is predominantly home-based and progressive, built upon disease education and activity modification. It is designed with reference to prior studies and systematic reviews, and comprises: (1) resistance training of the periarticular hip musculature; (2) functional motor-control training; (3) hip range-of-motion and flexibility training; and (4) trunk and pelvic stability training. The program is performed four times per week, with each session lasting approximately 30-45 minutes. After the baseline assessment, a rehabilitation therapist instructs participants in the exercises and provides training materials. During the intervention, training load, repetitions, range of motion, and exercise difficulty are individually adjusted according to each participant's symptoms, movement quality, and completion status. If symptoms markedly worsen after a session and do not resolve within 24 hours, the load is reduced and the relevant exercises are suspended; if necessary, the participant is evaluated by the rehabilitation therapist or a clinician. Training completion is recorded by the research staff.
Surgical Intervention (Arms A and B): Hip arthroscopic surgery is performed to resect the impinging osseous deformity and to repair or reconstruct the damaged labrum as appropriate. Detailed intraoperative findings, including labral damage, cartilage injury, round ligament and other intra-articular pathology, as well as the specific surgical procedures performed (labral repair/reconstruction, cartilage treatment, tendon repair, capsular management, osteotomy type and fixation where applicable), are documented.
Outcome Measures
Primary outcome measures:
Secondary outcome measures:
Data Management and Statistical Analysis Data are collected via structured questionnaires and entered into a dedicated database using double-entry by two independent operators, followed by two rounds of cross-checking. Queries are exchanged using query forms, which are retained for audit. After verification, the database is locked following review by the principal investigator, sponsor representatives, monitors, data manager, and statistician. Original records are archived according to applicable retention requirements, with multiple electronic backups stored on separate media.
Statistical analysis is performed using SPSS 26.0 software. Categorical data are expressed as percentages and compared between groups using the chi-square test. Continuous data are expressed as mean ± standard deviation and compared using t-tests or non-parametric tests as appropriate. Spearman correlation analysis and multiple linear regression are used to evaluate associations between psychosocial factors and surgical outcomes. Unless otherwise specified, a two-sided p-value \< 0.05 is considered statistically significant.
110 studies on the registry are indexed under Femoracetabular Impingement; 36 are open to participants now.
This study's planned enrollment of 360 is above the median of 75 across 63 interventional studies indexed under Femoracetabular Impingement.
Browse Femoracetabular Impingement studies →Peking University Third Hospital is the lead sponsor of 749 studies on the registry; 270 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A structured preoperative prehabilitation program followed by hip arthroscopic surgery
Procedure: Hip arthroscopic surgery · Behavioral: Standardized physical rehabilitation training
Conventional hip arthroscopic surgery without preoperative prehabilitation
Procedure: Hip arthroscopic surgery
A standardized rehabilitation program
Behavioral: Standardized physical rehabilitation training
Hip arthroscopic surgery
Standardized physical rehabilitation training
iHOT-12
International Hip Outcome Tool (iHOT-12) score
Time frame: 6 and 12 months
mHHS
Modified Harris Hip Score
Time frame: 6 and 12 months
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Jul 2036, 120 months after the start.
Of 37 non-industry interventional studies with no phase under Femoracetabular Impingement, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 30 and three quarters within 79. This study's planned 120 months is above that.
Counting every sponsor, half of 38 studies reached it within 41 months; a quarter within 30 and three quarters within 79.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Third Hospital →